Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry

Journal of Vascular Surgery

Volumn 56, Issue 4, 2012, Pages 1045-1051.e1

  De Martino, Randall R ^a   Beck, Adam W ^b   Edwards, Matthew S ^c   Corriere, Matthew A ^d   Wallaert, Jessica B ^a   Stone, David H ^a   Cronenwett, Jack L ^a   Goodney, Philip P ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABOVE KNEE AMPUTATION; AMPUTATION; AORTIC SURGERY; ARTICLE; BELOW KNEE AMPUTATION; BYPASS SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FOOT AMPUTATION; GASTRIC BYPASS SURGERY; HIP ARTHROPLASTY; HUMAN; INCIDENCE; LEG AMPUTATION; LOWER LIMB; MORBIDITY; OPEN SURGERY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSTATECTOMY; REFERENCE DATABASE; REGISTER; SCREENING; SURGICAL MORTALITY; SURGICAL PATIENT; TOTAL QUALITY MANAGEMENT; ADULT; COHORT ANALYSIS; HEALTH SURVEY; MASS SCREENING; POSTOPERATIVE COMPLICATION; REPRODUCIBILITY; RISK FACTOR; UNITED STATES; VEIN THROMBOSIS;

ADULT; COHORT STUDIES; HUMANS; INCIDENCE; MASS SCREENING; POPULATION SURVEILLANCE; POSTOPERATIVE COMPLICATIONS; QUALITY IMPROVEMENT; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UNITED STATES; VENOUS THROMBOSIS;

EID: 84872015309     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.02.066     Document Type: Article

References (56)

1. Agency for Healthcare Research and Quality (AHRQ). Quality indicators: guide to patient safety indicators: AHRQ quality indicators. 2006, Agency for Healthcare Research and Quality, Rockville, MD Rockville MD; 2011 http://www.qualityindicators.ahrq.gov/Modules/psi_resources.aspx Accessed December 2011.
2. Association APH. Coalition to prevent deep venous thrombosis. http://www.apha.org/programs/partnerships/dvt.htm, 2003 Accessed March 2011.
3. Office of the Surgeon General (US), National Heart, Lung, and Blood Institute (US). The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. Rockville (MD), 2008.
4. Pierce, C.A., Haut, E.R., Kardooni, S., Chang, D.C., Efron, D.T., Haider, A., et al. Surveillance bias and deep vein thrombosis in the national trauma data bank: the more we look, the more we find. J Trauma 64 (2008), 932–936 discussion 936-7.
5. McLachlin, J., Richards, T., Paterson, J.C., An evaluation of clinical signs in the diagnosis of venous thrombosis. Arch Surg 85 (1962), 738–744.
6. American College of Surgeons. National Surgical Quality Improvement Program. Web site http://www.acsnsqip.org/ Accessed June 2011.
7. Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:6 Suppl (2008), 381S–453S.
8. Yeager, R.A., Moneta, G.L., Edwards, J.M., Taylor, L.M. Jr, McConnell, D.B., Porter, J.M., Deep vein thrombosis associated with lower extremity amputation. J Vasc Surg 22 (1995), 612–615.
9. Fletcher, J.P., Batiste, P., Incidence of deep vein thrombosis following vascular surgery. Int Angiol 16 (1997), 65–68.
10. Burke, B., Kumar, R., Vickers, V., Grant, E., Scremin, E., Deep vein thrombosis after lower limb amputation. Am J Phys Med Rehabil 79 (2000), 145–149.
11. Lastória, S., Rollo, H.A., Yoshida, W.B., Giannini, M., Moura, R., Maffei, F.H., Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin. Acta Cir Bras 21 (2006), 184–186.
12. Bandeira, F.C., Pitta, G.B., Castro, A.A., Miranda, F. Jr, Postoperative incidence of deep vein thrombosis after major lower extremity amputation. Int Angiol 27 (2008), 489–493.
13. Matielo, M.F., Presti, C., Casella, I.B., Netto, B.M., Puech-Leão, P., Incidence of ipsilateral postoperative deep venous thrombosis in the amputated lower extremity of patients with peripheral obstructive arterial disease. J Vasc Surg 48 (2008), 1514–1519.
14. Farkas, J.C., Chapuis, C., Combe, S., Silsiguen, M., Marzelle, J., Laurian, C., et al. A randomised controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery. Eur J Vasc Surg 7 (1993), 554–560.
15. Passman, M.A., Farber, M.A., Marston, W.A., Carlin, R.E., Owens, L.V., Burnham, C.B., et al. Prospective screening for postoperative deep venous thrombosis in patients undergoing infrainguinal revascularization. J Vasc Surg 32 (2000), 669–675.
16. de Maistre, E., Terriat, B., Lesne-Padieu, A.S., Abello, N., Bouchot, O., Steinmetz, E.F., High incidence of venous thrombosis after surgery for abdominal aortic aneurysm. J Vasc Surg 49 (2009), 596–601.
17. Eagleton, M.J., Grigoryants, V., Peterson, D.A., Williams, D.M., Henke, P.K., Wakefield, T.W., et al. Endovascular treatment of abdominal aortic aneurysm is associated with a low incidence of deep venous thrombosis. J Vasc Surg 36 (2002), 912–916.
18. Killewich, L.A., Aswad, M.A., Sandager, G.P., Lilly, M.P., Flinn, W.R., A randomized, prospective trial of deep venous thrombosis prophylaxis in aortic surgery. Arch Surg 132 (1997), 499–504.
19. Olin, J.W., Graor, R.A., O'Hara, P., Young, J.R., The incidence of deep venous thrombosis in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg 18 (1993), 1037–1041.
20. Augustin, H., Hammerer, P., Graefen, M., Palisaar, J., Noldus, J., Fernandez, S., et al. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur Urol 43 (2003), 113–118.
21. Beyer, J., Wessela, S., Hakenberg, O.W., Kuhlisch, E., Halbritter, K., Froehner, M., et al. Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery. J Thromb Haemost 7 (2009), 597–604.
22. Cisek, L.J., Walsh, P.C., Thromboembolic complications following radical retropubic prostatectomy: Influence of external sequential pneumatic compression devices. Urology 42 (1993), 406–408.
23. Heinzer, H., Hammerer, P., Graefen, M., Huland, H., Thromboembolic complication rate after radical retropubic prostatectomy: Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas. Eur Urol 33 (1998), 86–90.
24. Kibel, A.S., Creager, M.A., Goldhaber, S.Z., Richie, J.P., Loughlin, K.R., Late venous thromboembolic disease after radical prostatectomy: effect of risk factors, warfarin and early discharge. J Urol 158 (1997), 2211–2215.
25. Koya, M.P., Manoharan, M., Kim, S.S., Soloway, M.S., Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?. BJU Int 96 (2005), 1019–1021.
26. Leibovitch, I., Foster, R.S., Wass, J.L., Rowland, R.G., Bihrle, R., Little, J.S. Jr, et al. Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma. J Urol 153 (1995), 1866–1869.
27. Secin, F.P., Jiborn, T., Bjartell, A.S., Fournier, G., Salomon, L., Abbou, C.C., et al. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 53 (2008), 134–145.
28. Brasileiro, A.L., Miranda, F. Jr, Ettinger, J.E., Castro, A.A., Pitta, G.B., de Moura, L.K., et al. Incidence of lower limbs deep vein thrombosis after open and laparoscopic gastric bypass: a prospective study. Obes Surg 18 (2008), 52–57.
29. Eriksson, S., Backman, L., Ljungström, K.G., The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years. Obes Surg 7 (1997), 332–335 discussion 336.
30. Escalante-Tattersfield, T., Tucker, O., Fajnwaks, P., Szomstein, S., Rosenthal, R.J., Incidence of deep vein thrombosis in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 4 (2008), 126–130.
31. Prystowsky, J.B., Morasch, M.D., Eskandari, M.K., Hungness, E.S., Nagle, A.P., Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery 138 (2005), 759–763 discussion 763-5.
32. Scholten, D.J., Hoedema, R.M., Scholten, S.E., A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12 (2002), 19–24.
33. Westling, A., Bergqvist, D., Boström, A., Karacagil, S., Gustavsson, S., Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg 26 (2002), 470–473.
34. Eriksson, B.I., Borris, L.C., Dahl, O.E., Haas, S., Huisman, M.V., Kakkar, A.K., et al. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation 114 (2006), 2374–2381.
35. Eriksson, B.I., Borris, L.C., Friedman, R.J., Haas, S., Huisman, M.V., Kakkar, A.K., et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358 (2008), 2765–2775.
36. Eriksson, B.I., Dahl, O.E., Rosencher, N., Kurth, A.A., van Dijk, C.N., Frostick, S.P., et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 370 (2007), 949–956.
37. Eriksson, B.I., Wille-Jørgensen, P., Kälebo, P., Mouret, P., Rosencher, N., Bösch, P., et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 337 (1997), 1329–1335.
38. Francis, C.W., Pellegrini, V.D. Jr, Totterman, S., Boyd, A.D. Jr, Marder, V.J., Liebert, K.M., et al. Prevention of deep-vein thrombosis after total hip arthroplasty: Comparison of warfarin and dalteparin. J Bone Joint Surg Am 79 (1997), 1365–1372.
39. Hamulyák, K., Lensing, A.W., van der Meer, J., Smid, W.M., van Ooy, A., Hoek, J.A., Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement?: Fraxiparine Oral Anticoagulant Study Group. Thromb Haemost 74 (1995), 1428–1431.
40. Hull, R., Raskob, G., Pineo, G., Rosenbloom, D., Evans, W., Mallory, T., et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 329 (1993), 1370–1376.
41. Hull, R.D., Pineo, G.F., Francis, C., Bergqvist, D., Fellenius, C., Soderberg, K., et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison: The North American Fragmin Trial Investigators. Arch Intern Med 160 (2000), 2199–2207.
42. Lassen, M.R., Bauer, K.A., Eriksson, B.I., Turpie, A.G., European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 359 (2002), 1715–1720.
43. Manganelli, D., Pazzagli, M., Mazzantini, D., Punzi, G., Manca, M., Vignali, C., et al. Prolonged prophylaxis with unfractioned heparin is effective to reduce delayed deep vein thrombosis in total hip replacement. Respiration 65 (1998), 369–374.
44. Pitto, R.P., Hamer, H., Heiss-Dunlop, W., Kuehle, J., Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg Br 86 (2004), 639–642.
45. Planès, A., Samama, M.M., Lensing, A.W., Büller, H.R., Barre, J., Vochelle, N., et al. Prevention of deep vein thrombosis after hip replacement–comparison between two low-molecular heparins, tinzaparin and enoxaparin. Thromb Haemost 81 (1999), 22–25.
46. Planès, A., Vochelle, N., Fagola, M., Bellaud, M., Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery: Reviparin Study Group. Blood Coagul Fibrinolysis 9 (1998), 499–505.
47. Prandoni, P., Bruchi, O., Sabbion, P., Tanduo, C., Scudeller, A., Sardella, C., et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med 162 (2002), 1966–1971.
48. Turpie, A.G., Bauer, K.A., Eriksson, B.I., Lassen, M.R., PENTATHALON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 359 (2002), 1721–1726.
49. Raskob, G.E., Silverstein, R., Bratzler, D.W., Heit, J.A., White, R.H., Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 38:4 Suppl (2010), S502–S509.
50. Haut, E.R., Schneider, E.B., Patel, A., Streiff, M.B., Haider, A.H., Stevens, K.A., et al. Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices. J Trauma 70 (2011), 27–33 discussion 33-4.
51. Misra, M., Roitberg, B., Ebersole, K., Charbel, F.T., Prevention of pulmonary embolism by combined modalities of thromboprophylaxis and intensive surveillance protocol. Neurosurgery 54 (2004), 1099–1102 discussion 1102-3.
52. Henwood, P.C., Kennedy, T.M., Thomson, L., Galanis, T., Tzanis, G.L., Merli, G.J., et al. The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis. J Thromb Thrombolysis 32 (2011), 209–214.
53. Flinn, W.R., Sandager, G.P., Silva, M.B. Jr, Benjamin, M.E., Cerullo, L.J., Taylor, M., Prospective surveillance for perioperative venous thrombosis: Experience in 2643 patients. Arch Surg 131 (1996), 472–480.
54. Kearon, C., Kahn, S.R., Agnelli, G., Goldhaber, S., Raskob, G.E., Comerota, A.J., Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:6 Suppl (2008), 454S–545S.
55. American College of Surgeons. http://www.facs.org/cqi/outcomes.html Accessed July 8, 2011.
56. Jancin, B., NSQIP found highly cost effective for participating hospitals 2010. http://infoviewer.biz/infodisplay/story/imn051320111612595086.html?APP=7&CU=imn5804, 2011 Accessed November 30, 2011.